Cleveland State University

EngagedScholarship@CSU
Chemical & Biomedical Engineering Faculty
Publications

Chemical & Biomedical Engineering Department

1-2003

Clinical Blood Flow Quantification with Segmented k-Space
Magnetic Resonance Phase Velocity Mapping
George P. Chatzimavroudis
Cleveland State University

Haosen Zhang
Cleveland
University works at: https://engagedscholarship.csuohio.edu/encbe_facpub
Follow
thisState
and additional
Part S.
of the
Bioimaging and Biomedical Optics Commons
Sandra
Halliburton
Cleveland
Foundation
How doesClinic
access
to this work benefit you? Let us know!

Publisher's
Statement
James R. Moore

This is the
accepted
version
Siemens
Medical
Solutions
USAof the following article: Chatzimavroudis GP, Zhang H, Halliburton
SS, Moore JR, Simonetti OP, Schvartzman PR, Stillman AE, White RD. Clinical blood flow
Orlando Simonetti
quantification with segmented k-space magnetic resonance phase velocity mapping. Journal of
Siemens Medical Solutions USA
Magnetic Resonance Imaging. 2003;17:65-71., which has been published in final form at
http://onlinelibrary.wiley.com/doi/10.1002/jmri.10231/abstract
See next page for additional authors

Original Citation
Chatzimavroudis GP, Zhang H, Halliburton SS, Moore JR, Simonetti OP, Schvartzman PR, Stillman AE,
White RD. Clinical blood flow quantification with segmented k-space magnetic resonance phase velocity
mapping. Journal of Magnetic Resonance Imaging. 2003;17:65-71.

Repository Citation

Chatzimavroudis, George P.; Zhang, Haosen; Halliburton, Sandra S.; Moore, James R.; Simonetti, Orlando;
Schvartzman, Paulo R.; Stillman, Arthur E.; and White, Richard D., "Clinical Blood Flow Quantification with
Segmented k-Space Magnetic Resonance Phase Velocity Mapping" (2003). Chemical & Biomedical Engineering
Faculty Publications. 108.
https://engagedscholarship.csuohio.edu/encbe_facpub/108
This Article is brought to you for free and open access by the Chemical & Biomedical Engineering Department at
EngagedScholarship@CSU. It has been accepted for inclusion in Chemical & Biomedical Engineering Faculty
Publications by an authorized administrator of EngagedScholarship@CSU. For more information, please contact
library.es@csuohio.edu.

Authors
George P. Chatzimavroudis, Haosen Zhang, Sandra S. Halliburton, James R. Moore, Orlando Simonetti,
Paulo R. Schvartzman, Arthur E. Stillman, and Richard D. White

This article is available at EngagedScholarship@CSU: https://engagedscholarship.csuohio.edu/encbe_facpub/108

Clinical Blood Flow Quantiﬁcation With Segmented
k-Space Magnetic Resonance Phase Velocity
Mapping
George P. Chatzimavroudis, PhD,1,2* Haosen Zhang, MS,2 Sandra S. Halliburton, PhD,1,2
James R. Moore, PhD,3 Orlando P. Simonetti, PhD,3 Paulo R. Schvartzman, MD,1
Arthur E. Stillman, MD,1 and Richard D. White, MD1
Purpose: To evaluate the accuracy of segmented k-space
magnetic resonance phase velocity mapping (PVM) in
quantifying aortic blood ﬂow from through-plane velocity
measurements.
Materials and Methods: Two segmented PVM schemes were
evaluated, one with seven lines per segment (seg-7) and one
with nine lines per segment (seg-9), in twenty patients with
cardiovascular disease. A non-segmented (non-seg) PVM ac
quisition was also performed to provide the reference data.
Results: There was agreement between the aortic ﬂow curves
acquired with segmented and non-segmented PVM. The cal
culated systolic and total ﬂow volume per cycle from the seg-7
and the seg-9 scans correlated and agreed with the ﬂow vol
umes from the non-seg scans (differences < 5%). Sign tests
showed that there were no statistically signiﬁcant differences
(P-values < 0.05) between the segmented and the non-seg
mented PVM measurements. Seg-9, which was the fastest
among the three sequences, provided adequate spatial and
temporal resolution (> 10 phases per cycle).
Conclusion: Segmented k-space PVM shows great clinical
potential in blood ﬂow quantiﬁcation.
Key Words: magnetic resonance imaging; magnetic reso
nance phase velocity mapping; segmented k-space; blood
ﬂow; ﬂow quantiﬁcation; aorta; velocity

MAGNETIC RESONANCE (MR) phase velocity mapping
(PVM) has been widely used clinically to measure blood
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velocity and ﬂow. The technique is based on the prin
ciple that, by using the proper bipolar magnetic ﬁeld
gradients in the direction of interest, the velocity of the
spins in that direction can be encoded within the phase
of the detected signal (1). There have been many in vitro
and in vivo studies evaluating PVM for ﬂow quantiﬁca
tion (2–17). For in vitro studies, the accuracy and pre
cision of PVM was found to be consistently high, with
errors lower than 10% (2–7). In vivo studies showed a
good correlation between PVM and Doppler ultrasound
or other ﬂowmetric techniques (2,4,8 –11). PVM has
been extensively used to visualize and quantify cardiac,
arterial, and venous blood ﬂow with high precision
(7,10 –17).
Conventional PVM involves a non-segmented gradi
ent-echo sequence with bipolar velocity-encoding gra
dients in the direction(s) of interest. The acquisition is
prospectively or retrospectively ECG-gated to acquire a
number of time-phases throughout the cardiac cycle.
Only one line of k-space is acquired for each time-phase
per cardiac cycle, resulting in a scanning time of several
minutes (usually three to ﬁve minutes, depending on
functional and imaging parameters) for acquisition of a
single velocity direction in one imaging slice. Considering that PVM measurements constitute only part of a
complete cardiac MR examination and that new diag
nostic approaches have involved multi-slice and multi
directional velocity acquisitions (6,18,19), this non-seg
mented, single k-space line scheme becomes less
practical clinically.
With the development of rapid imaging sequences,
such as turbo gradient echo (TGE) and echo planar,
faster PVM has become possible (20 –31). Instead of a
single k-space line, a segment of k-space lines are ac
quired per time-phase and cardiac cycle. As a result,
the acquisition can be performed in seconds. Seg
mented TGE has shown good ﬂow-behavior and can
provide high temporal and spatial resolution acquisi
tions. It is, therefore, promising for reliable rapid ﬂow
quantiﬁcation even in cases of moderately disturbed
ﬂow and vessel motion (25–31).
In a recent in vitro study (31), we showed that seg
mented k-space PVM provides accurate ﬂow results
under steady and pulsatile ﬂow conditions (errors <
5%). Segmented PVM measurements with ﬁve, seven,

and nine k-space lines per segment agreed very closely
with non-segmented measurements under identical ex
perimental conditions. Therefore, the aim of the present
study was to clinically evaluate segmented PVM as a
blood ﬂow quantiﬁcation technique, by measuring
blood ﬂow in the human ascending aorta. Of interest
was the effect of increasing the number of k-space lines
per segment on the accuracy of the results.

MATERIALS AND METHODS
MR PVM measurements were performed in the ascend
ing aorta of twenty patients with cardiovascular disease
(16 males, average age 61 years; four females, average
age 73 years) using a 1.5 Tesla whole-body MRI scanner
(Sonata, Siemens Medical Solutions, Erlangen, Ger
many) with a maximum gradient strength of 40
mTesla/m. Thirteen patients had aortic dilatation and
aneurysms (six with aortic regurgitation) with mid-as
cending aorta diameter 4.5– 6.0 cm. Six patients had
ischemic heart disease (two with mitral regurgitation,
one with combined aortic stenosis/aortic regurgita
tion/mitral regurgitation). One patient had a left ven
tricular aneurysm. The study protocol was approved by
the Institutional Review Board of the Cleveland Clinic
Foundation.
Initial true-FISP (fast imaging with steady-state pre
cession) scout images in all three spatial orientations
(axial, coronal, and sagittal) showed the location of the
ascending aorta. The through-plane velocity of blood
was measured in an imaging slice placed perpendicular
to the long-axis of the ascending aorta, at the level of
pulmonary artery bifurcation. Three PVM acquisitions
were performed, at the same location in each subject,
using the following three sequences: (a) conventional
non-segmented gradient echo (non-seg); (b) segmented
TGE with seven k-space lines per time-phase and car
diac cycle (seg-7); and (c) segmented TGE with nine
lines per time-phase and cycle (seg-9).
The non-seg scans were 120 –180 seconds long,
whereas the segmented scans were 10 –16 seconds
long, depending on the heart rate. Each of the seg
mented k-space scans was performed during a breathhold. In all sequences, the ﬂow-sensitive and the ﬂowcompensated data were acquired in an interleaved
manner in the same cycle. The ﬂip angle was 30°. The
slice thickness was 5 mm. The scan percentage factor
(percentage of k-space ﬁlled) was 75% for the non-seg
scans, 55% for the seg-7 scans, and 56% for the seg-9
scans. The 75% rectangular ﬁeld of view (FOV) was
varied from 210 � 280 mm2 to 263 � 350 mm2, de
pending on patient size. Combination of the scan per
centage factor with the rectangular FOV factor resulted
in an acquired number of 144, 105, and 108 ky-lines for
the non-seg, seg-7, and seg-9 scans, respectively. The
nominal voxel size varied between 1.5 � 1.1 � 5.0 mm3
and 1.8 � 1.4 � 5.0 mm3 for sequence (a), between
2.0 � 1.1 � 5.0 mm3 and 2.5 � 1.4 � 5.0 mm3 for
sequence (b), and between 1.9 � 1.1 � 5.0 mm3 and
2.4 � 1.4 � 5.0 mm3 for sequence (c). Therefore, for a
reconstructed matrix of 256 � 256, the interpolated

voxel size varied from 1.1 � 1.1 � 5.0 mm3 to 1.4 �
1.4 � 5.0 mm3 in all sequences.
The shortest (2.3–3.0 msec) allowable echo time (TE)
was used for all measurements. All acquisitions were
prospectively ECG-gated, resulting in 19 –35, 13–25,
and 11–21 time-phases per cycle for the non-seg, seg-7,
and seg-9 acquisitions, respectively. The temporal res
olution of the segmented acquisitions was improved by
using echo view-sharing (32). The resulting resolution
was 30 msec, 40 – 46 msec, and 50 –57 msec for the
non-seg, seg-7, and seg-9 acquisitions, respectively.
The time corresponding to each time-phase was the
time of acquisition of the central line of the segment,
since that line contained the most useful velocity infor
mation of the segment.
In the non-seg sequence, the repetition time (TR) was
15 msec. In seg-7 and seg-9, the time to acquire data for
any one ky-line (actual TR) varied between 5.2 msec and
5.6 msec, depending on imaging parameters such as
FOV. The echo was acquired asymmetrically within the
data acquisition period. The peak of the echo occurred
at data-point 82 of 256 and the missing data points
were zero-ﬁlled. The velocity encoding value was 250
cm/second.
Each PVM acquisition produced a series of magni
tude and phase images. All images were transferred to a
work-station (Ultra-10, SUN Microsystems, Inc., Palo
Alto, CA). A FORTRAN program was used to examine
the images for the presence of any residual phase off
sets (5,33). When phase offsets were detected, they were
removed based on a two-dimensional regression anal
ysis model, and the phase values of the phase images
were converted to velocity values (cm/second), based
on their proportionality. The images were further pro
cessed using Transform (Version 3.4, Research Sys
tems, Inc., Boulder, CO) to calculate the ﬂow rates and
ﬂow volumes. The aortic cross-section was deﬁned as
the region of interest, and the velocity was integrated
over the aortic cross-sectional area to determine the
ﬂow rate (mL/second) through the aorta for each timephase. Integration of the aortic ﬂow curve over systole
and over the entire cardiac cycle provided the systolic
and total ﬂow volumes (mL/cycle), respectively. When
no phase offset was detected, the images were pro
cessed using manufacturer software (ARGUS Cardiac
Analysis, Siemens Medical Solutions, Erlangen, Ger
many) in order to automatically calculate the ﬂow rates
and ﬂow volumes.
Statistical analysis, including non-parametric sign
tests, regression analysis, and t-tests, was performed to
compare the ﬂow data from the segmented acquisitions
with the ﬂow data from the non-segmented acquisi
tions. Most of the statistics was performed using
Minitab (Version 13, Minitab, Inc., State College, PA).
RESULTS
Figure 1 shows representative magnitude and phase
images from the non-seg and seg-9 PVM acquisitions
from one subject at peak systole. Both sets of images
are of sufﬁcient quality for reliable analysis and ﬂow
quantiﬁcation. Similar image quality was observed in
all subjects for all three sequences used.

Figure 1. Magnitude (left) and phase
(right) images acquired in the same sub
ject using the non-segmented sequence
(top) and the segmented sequence with
nine lines per segment (bottom). Both
sets of images are of sufﬁcient quality for
ﬂow quantiﬁcation analysis.

As expected, the seg-7 acquisitions provided higher
temporal resolution than the seg-9 acquisitions (13–25
time-phases for seg-7 vs. 11–21 time-phases for seg-9);
however, seg-9 provided greater scanning speed (13–16
seconds for seg-7 vs. 10 –13 seconds for seg-9).
The ﬂow curves obtained using the segmented acqui
sitions agreed with the curves obtained using the nonsegmented acquisitions, as seen in Figure 2 for four
representative cases. In patients with aortic regurgita
tion, the ﬂow curves showed diastolic reverse ﬂow ac
tivity, as expected (e.g., subject 17, Fig. 2). Table 1
shows all of the ﬂow volume results.
The results for the systolic and the total ﬂow volumes
from the segmented PVM acquisitions showed a close
correlation (Pearson coefﬁcients 2 0.94, Table 2) and
agreement (mean difference < 5%) with those from the
non-segmented acquisitions. Sign tests showed no sta
tistically signiﬁcant differences (P-values > 0.05) be
tween the segmented and the non-segmented PVM
measurements (Table 2). Figures 3 and 4 show the
regression analysis results from the comparison be
tween the segmented and the non-segmented systolic
and total ﬂow volumes, respectively. In all cases, the
regression lines have slopes not signiﬁcantly different
from 1.0, and intercepts not signiﬁcantly different from
zero (as statistically determined via t-tests with P-val
ues > 0.05). In addition, the coefﬁcients of determina
tion are large (r2 > 0.88), and the standard errors small
(Table 2). Good correlation (Pearson coefﬁcient 2 0.97,
Table 2) and no statistically signiﬁcant differences were
also found between the seg-7 and seg-9 ﬂow volume

results (refer to the regression analysis and sign test
results in Fig. 5 and Table 2).
DISCUSSION
Non-segmented MR PVM is an accurate and precise
velocimetric and ﬂow quantiﬁcation technique, and has
been used clinically to measure blood ﬂow and charac
terize blood ﬂow patterns throughout the cardiovascu
lar system. Despite its advantages, it is relatively slow,
requiring several minutes for acquisition of a single
velocity component in a slice. With the development of
segmented k-space acquisition schemes, rapid PVM
has become available.
We recently evaluated the in vitro accuracy of seg
mented PVM with ﬁve, seven, and nine lines per seg
ment under a variety of ﬂow conditions (31). The results
showed that segmented k-space PVM has high potential
for blood ﬂow quantiﬁcation. Based on the positive in
vitro results, the aim of the present study was to clini
cally evaluate the potential of segmented PVM to quan
tify blood ﬂow in the aorta of human subjects. We did
not evaluate the segmented scheme with ﬁve lines per
segment clinically, because it would generally require
more than 20 seconds per acquisition. A breath-hold of
such duration may be difﬁcult to achieve for many pa
tients.
Due to the lack of a universally acceptable goldstandard blood ﬂow quantiﬁcation technique, in this
study we considered non-segmented PVM as the ref
erence technique. This can be justiﬁed by the large

Figure 2. Measured aortic
ﬂow waveforms in four sub
jects using the non-seg
mented sequence, and two
segmented sequences with
seven and nine k-space lines
per segment. A good agree
ment can be observed in all
cases between the three se
quences.

number of previous evaluations of the non-seg
mented technique both in vitro and in vivo. Therefore,
a comparison between segmented and non-seg
mented k-space PVM can provide important informa
tion about the reliability of segmented PVM as a ﬂow
quantiﬁcation technique.
Image quality was good for all sequences used, facil
itating image analysis and processing. The aortic crosssection could easily be identiﬁed for further analysis.
Although the in-plane spatial resolution (= 1–3 mm2)
was adequate to obtain the details of the velocity proﬁle
for a large vessel such as the ascending aorta, an even

higher resolution (however, at the expense of scanning
time) would be required for smaller vessels, as previ
ously observed in vitro (31). Higher spatial resolution
would also better resolve the velocity gradients imme
diately adjacent to the vessel wall (important to accu
rately calculate wall shear stress). However, the effects
of reducing voxel size on the signal-to-noise ratio and,
thus, image quality in vivo need to be thoroughly inves
tigated.
The measured aortic ﬂow curves in all subjects
were very similar for all three sequences (non-seg,
seg-7, and seg-9). It should be noted that, in seg-

Table 1
Flow Volume Results
Subject no.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Systolic volume, ml/cycle

Total volume, ml/cycle

Non-Seg

Seg-7

Seg-9

Non-Seg

Seg-7

Seg-9

90.1
41.8
55.8
67.8
57.5
45.3
67.9
57.9
52.4
54.8
63.8
72.4
68
37.2
48.5
71.9
72.2
72.6
66.2
70.5

91.7
41.1
58.4
67.3
61.9
49
67.9
59.4
49.1
55.9
63.7
66.1
64
40.2
48.3
70.9
77
67.8
65.1
75.8

90.3
42.9
59.4
69.4
58.9
47.9
68.9
57.3
48.5
57
64.3
69.6
67.2
37.2
47.3
73.9
78.3
74.2
64
72.3

88.1
36.6
36.8
64.6
57.0
44.2
67.1
59.1
48.4
53.7
58.5
77.7
60.5
40.7
39.9
69.8
53.9
53.5
68.0
53.8

90.8
39.2
37.2
60.2
58.8
50.1
64.1
43.9
47.8
52.7
57.4
76.1
67.1
36.1
36.6
67.3
50.5
56.8
70.2
58.6

86.1
36.0
33.7
66.8
58.3
54.2
62.6
48.7
46.4
53.3
61.0
82.4
68.4
42.7
36.3
73.2
51.8
56.5
71.4
57.2

Non-Seg = non-segmented; Seg-7 = segmented with seven lines per segment; Seg-9 = segmented with nine lines per segment.

Table 2
Regression Analysis and Other Statistics
Y
(mL/second)
Systolic ﬂow volume
Seg-7
Seg-9
Seg-9
Total ﬂow volume
Seg-7
Seg-9
Seg-9

Regression
equation

R2

SE
(mL/second)

Non-Seg
Non-Seg
Seg-7

Y = 0.95 X + 3.38
Y = 1.01 X - 0.14
Y = 1.03 X - 1.40

0.937
0.970
0.964

3.2
2.3
2.6

Non-Seg
Non-Seg
Seg-7

Y = 0.99 X + 0.26
Y = 1.02 X - 0.57
Y = 1.00 X + 1.44

0.885
0.903
0.942

5.0
4.7
3.6

X
(mL/second)

Sign test
P-value

Pearson
correlation
coefﬁcient

0.8
1.1
0.5

1.0
0.2
0.8

0.97
0.99
0.98

-0.8
1.2
2.3

0.8
0.8
0.8

0.94
0.95
0.97

Mean %
difference

SE = standard error; Seg-7 = segmented with seven lines per segment; Seg-9 = segmented with nine lines per segment; Non-Seg=non
segmented.

mented PVM with N lines per segment (where N is
an odd number), the most inﬂuential information
is contained in the central line of the segment,
(N+1)/2, because this is the closest line of the seg
ment to the center of k-space. Therefore, the time
point corresponding to each cardiac phase was
adjusted to be the time of acquisition of the cen
tral k-space line of the segment. As a result, the
segmented techniques cannot acquire data at the
very beginning of the cardiac cycle when they are
prospectively ECG-gated (in this study, the ﬁrst
time phase in the cycle corresponded to 8, 40, and
50 msec after the QRS wave, for the non-seg, seg
7, and seg-9 acquisitions, respectively). This may
cause uncertainties in measurements for patients
with very rapid early systolic ﬂow acceleration. Use of
retrospective ECG-gating should eliminate this prob
lem.

The seg-7 and seg-9 ﬂow volume (systolic and total)
results showed strong correlation and agreement
with the non-seg ﬂow volume results, suggesting that
reliable blood ﬂow quantiﬁcation is possible using
ultra-fast segmented PVM. Increasing the number of
k-space lines per segment to nine did not adversely
affect the ability to sufﬁciently resolve the ﬂow wave
forms. The seg-9 scans were faster than the seg-7
scans by approximately three seconds, and provided
acquisitions with good temporal resolution (> 10 time
phases per cycle). Increasing the number of k-space
lines per segment above nine will certainly shorten
the acquisition even more, but at the expense of tem
poral resolution. Reducing the temporal resolution
may cause uncertainties in determining local velocity
values such as peak systolic velocities. Therefore, the
number of lines should be further increased only

Figure 3. Comparison between the systolic ﬂow volumes mea
sured with the non-segmented and the two segmented se
quences (non-Seg: non-segmented acquisition; Seg-7: seg
mented acquisition with seven k-space lines per segment;
Seg-9: segmented acquisition with nine k-space lines per seg
ment). The diagonal line is the line of identity.

Figure 4. Comparison between the total ﬂow volumes mea
sured with the non-segmented and the two segmented se
quences (non-Seg: non-segmented acquisition; Seg-7: seg
mented acquisition with seven k-space lines per segment;
Seg-9: segmented acquisition with nine k-space lines per seg
ment). The diagonal line is the line of identity.

Figure 5. Comparison between the ﬂow volumes (systolic and
total) measured with the two segmented sequences (Seg-7:
segmented acquisition with seven k-space lines per segment;
Seg-9: segmented acquisition with nine k-space lines per seg
ment). The diagonal line is the line of identity.

after assuring acquisition of an adequate number of
time phases per cycle to prevent loss of valuable in
formation and evaluating the acquisition technique
in vitro and in vivo.
In conclusion, segmented k-space magnetic reso
nance phase velocity mapping in the human ascend
ing aorta produced ﬂow results that agreed with
those from non-segmented acquisitions. Increasing
the number of lines per segment to nine allowed
very fast acquisitions (< 15 seconds) with adequate
temporal resolution (less than 60 msec between suc
cessive time phases). Segmented k-space MRPVM
shows great clinical potential in blood ﬂow quantiﬁ
cation.
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